Vectus Biosystems Limited (VBS) Stock Statistics & Valuation Metrics

Vectus Biosystems Limited has a market cap or net worth of AU$10.80M. The enterprise value is AU$8.15M.

Vectus Biosystems Limited has 61,690,350 shares outstanding. The number of shares has decreased by -2.65% in one year.

Vectus Biosystems Limited’s return on equity (ROE) is 6.93 and return on invested capital (ROIC) is 2347.56%.

The current PE Ratio of Vectus Biosystems Limited is ―. Vectus Biosystems Limited’s PEG ratio is 0.05.

In the last 12 months, Vectus Biosystems Limited had revenue of 478.18K and earned -1.78M in profits. Earnings per share was -0.03.

In the last 12 months, operating cash flow was -830.47K and capital expenditures 2.00, giving a free cash flow of -830.47K billion.

Vectus Biosystems Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Vectus Biosystems Limited upcoming earnings date is Sep 2, 2026, TBA (Confirmed).

Vectus Biosystems Limited as a current ratio of 0.93, with Debt / Equity ratio of -57.93%

In the past 12 months, Vectus Biosystems Limited has paid -461.18K in taxes.

Vectus Biosystems Limited EV to EBITDA ratio is -1.23, with an EV/FCF ratio of -2.50.

Vectus Biosystems Limited has AU$330.50K in cash and marketable securities with AU$467.10K in debt, giving a net cash position of -AU$136.60K billion.

Gross margin is 98.13%, with operating margin of -352.95%, and net profit margin of -371.67%.

The average price target for Vectus Biosystems Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―